Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02943317 |
| Title | Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer |
| Recruitment | Terminated |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Verastem, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Florida Cancer Specialists & Research Institute (FCS) | Sarasota | Florida | 34232 | United States | Details | |
| Dana Farber Cancer Instiyute | Boston | Massachusetts | 02215 | United States | Details | |
| Stephenson Cancer Center (University of Oklahoma) | Oklahoma City | Oklahoma | 73104 | United States | Details | |
| Sarah Cannon Research Institute at Tennessee Oncology | Nashville | Tennessee | 37203 | United States | Details | |
| Mary Crowley Cancer Research Centers | Dallas | Texas | 75251 | United States | Details |